Abstract:Effective and accurate diagnosis of Alzheimer's disease (AD), as well as its prodromal stage (i.e., mild cognitive impairment (MCI)), has attracted more and more attention recently. So far, multiple biomarkers have been shown to be sensitive to the diagnosis of AD and MCI, i.e., structural MR imaging (MRI) for brain atrophy measurement, functional imaging (e.g., FDG-PET) for hypometabolism quantification, and cerebrospinal fluid (CSF) for quantification of specific proteins. However, most existing research focuses on only a single modality of biomarkers for diagnosis of AD and MCI, although recent studies have shown that different biomarkers may provide complementary information for the diagnosis of AD and MCI. In this paper, we propose to combine three modalities of biomarkers, i.e., MRI, FDG-PET, and CSF biomarkers, to discriminate between AD (or MCI) and healthy controls, using a kernel combination method. Specifically, ADNI baseline MRI, FDG-PET, and CSF data from 51AD patients, 99 MCI patients (including 43 MCI converters who had converted to AD within 18 months and 56 MCI non-converters who had not converted to AD within 18 months), and 52 healthy controls are used for development and validation of our proposed multimodal classification method. In particular, for each MR or FDG-PET image, 93 volumetric features are extracted from the 93 regions of interest (ROIs), automatically labeled by an atlas warping algorithm. For CSF biomarkers, their original values are directly used as features. Then, a linear support vector machine (SVM) is adopted to evaluate the classification accuracy, using a 10-fold cross-validation. As a result, for classifying AD from healthy controls, we achieve a classification accuracy of 93.2% (with a sensitivity of 93% and a specificity of 93.3%) when combining all three modalities of biomarkers, and only 86.5% when using even the best individual modality of biomarkers. Similarly, for classifying MCI from healthy controls, we achieve a classification accuracy of 76.4% (with a sensitivity of 81.8% and a specificity of 66%) for our combined method, and only 72% even using the best individual modality of biomarkers. Further analysis on MCI sensitivity of our combined method indicates that 91.5% of MCI converters and 73.4% of MCI non-converters are correctly classified. Moreover, we also evaluate the classification performance when employing a feature selection method to select the most discriminative MR and FDG-PET features. Again, our combined method shows considerably better performance, compared to the case of using an individual modality of biomarkers.

Enhancing the Feature Representation of Multi-Modal MRI Data by Combining Multi-View Information for MCI Classification

Identification of Early Mild Cognitive Impairment Using Multi-Modal Data and Graph Convolutional Networks.

Multiple Connection Pattern Combination from Single-Mode Data for Mild Cognitive Impairment Identification

Multi-scale Features Extraction from Baseline Structure MRI for MCI Patient Classification and AD Early Diagnosis

Inter-modality Relationship Constrained Multi-Modality Multi-Task Feature Selection for Alzheimer's Disease and Mild Cognitive Impairment Identification.

MMHGE: Detecting Mild Cognitive Impairment Based on Multi-Atlas Multi-View Hybrid Graph Convolutional Networks and Ensemble Learning

Multimodal classification of Alzheimer's disease and mild cognitive impairment

Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment

A Multi-Modal and Multi-Atlas Integrated Framework for Identification of Mild Cognitive Impairment

Multi-Modal Feature Selection with Feature Correlation and Feature Structure Fusion for MCI and AD Classification

Multi-task Sparse Classifier for Diagnosis of MCI Conversion to AD with Longitudinal MR Images

Brain MR Image Classification for Alzheimer’s Disease Diagnosis Based on Multifeature Fusion

Identification of MCI individuals using structural and functional connectivity networks

Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment

A deep feature fusion network with global context and cross-dimensional dependencies for classification of mild cognitive impairment from brain MRI

Classification of MR brain images by combination of multi-CNNs for AD diagnosis

Improving Alzheimer's Disease Classification by Combining Multiple Measures

Towards Effective Classification of Amci Based on Resting-State Multiscale Brain Features and Machine Learning Approaches

Mild Cognitive Impairment Identification Based on Multi-View Graph Convolutional Networks

Multi-level fusion network for mild cognitive impairment identification using multi-modal neuroimages

Identification of Amnestic Mild Cognitive Impairment Using Multi-Modal Brain Features: A Combined Structural MRI and Diffusion Tensor Imaging Study.